| 1. |
阻塞性睡眠呼吸暫停低通氣綜合征診治指南(基層版)寫作組. 阻塞性睡眠呼吸暫停低通氣綜合征診治指南(基層版). 中國呼吸與危重監護雜志, 2015, 14(4): 398-405.
|
| 2. |
Watson NF. Health care savings: the economic value of diagnostic and therape tic care for obstructive sleep apnea. J Clin Sleep Med, 2016, 12(8): 1075-1077.
|
| 3. |
Shi Q, Wang R, Zhang H, et al. Association between serum uric acid and cardiovascular disease risk factors in adolescents in America: 2001-2018. PLoS One, 2021, 16(8): e0254590.
|
| 4. |
Chen J. Serum Uric acid level and all-cause and cardiovascular mortality in Chinese elderly: a community-based cohort study in Shanghai. Nutr Metab Cardiovasc Dis, 2021, 31(12): 3367-3376.
|
| 5. |
Bartziokas K, Papaioannou AI, Haniotou A, et al. Serum uric acid and arterial lactate levels in patients with obstructive sleep apnea syndrome: the effect of CPAP treatment. Postgrad Med, 2021, 133(5): 518-524.
|
| 6. |
Popadic V, Brajkovic M, Klasnja S, et al. Correlation of dyslipidemia and inflammation with obstructive sleep apnea severity. Front Pharmacol, 2022, 13: 897279.
|
| 7. |
Floras JS. Sleep apnea and cardiovascular disease an enigmatic risk factor. Circ Res, 2018, 122(12): 1741-1764.
|
| 8. |
王立曼, 周光耀, 劉亞峰, 等. 阻塞性睡眠呼吸暫停低通氣綜合征男女患者生物學特征分析. 中國呼吸與危重監護雜志, 2010, 9(5): 501-503.
|
| 9. |
Sunnetcioglu A, Sertogullar?ndan B, Ozbay B, et al. Obstructive sleep apnea related to rapid -eyemovement or non-rapid-eye-movement sleep: comparison of demographic, anthropometric, and polysomnographic features. J Bras Pneumol, 2016, 42(1): 48-54.
|
| 10. |
Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med, 2000, 342(19): 1378-1384.
|
| 11. |
Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F. Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med, 2013, 1(1): 61-72.
|
| 12. |
Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet, 2002, 359(9302): 204-210.
|
| 13. |
Bouloukaki I, Mermigkis C, Tzanakis N, et al. Evaluation of inflammatory markers in a large sample of obstructive sleep apnea patients without comorbidities. Mediators Inflamm, 2017, 2017: 4573756.
|
| 14. |
Shi T, Min M, Sun C, et al. A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea. Sleep Breath, 2019, 23(4): 1047-1057.
|
| 15. |
劉小麗, 羅倩, 黃玉蓉. 阻塞性睡眠呼吸暫停與尿酸水平相關性分析. 兵團醫學, 2019(4): 5-7.
|
| 16. |
郭世放. 阻塞性睡眠呼吸暫停低通氣綜合征腎功能損害的危險因素研究. 鄭州大學, 2017.
|
| 17. |
Tada T, Kusano KF, Ogawa A, et al. The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant, 2007, 22(4): 1190-1197.
|
| 18. |
李建鋒, 欒煜, 秦海強. 心血管疾病絕對風險評估循證醫學指南. 中國卒中雜志, 2009, 4(8): 683-686.
|
| 19. |
李慧敏, 熊夢清, 胡克, 等. 阻塞性睡眠呼吸暫停患者血清尿酸水平與心血管事件的相關性. 國際呼吸雜志, 2018, 38(6): 449-453.
|
| 20. |
Jujo K, Minam Y, Haruki S, et al. Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure. ESC Heart Fail, 2017, 4(4): 545-553.
|
| 21. |
Lan Q, Zheng L, Zhou X, et al. The value of blood urea nitrogen in the prediction of risks of cardiovascular disease in an older population. Front Cardiovasc Med, 2021, 8: 614117.
|